Tilmaamaha Waxqabadka
Xadka lagu ogaanayo: 5ng/ml;
Qiyaasta tooska ah: 5.00 ~ 400.00 ng/ml;
Isku-xirnaanta tooska ah ee R ≥0.990;
Saxnimada: CV dufcaddii waa ≤15%;inta u dhaxaysa dufcadaha CV waa ≤20%;
Saxnimada: leexashada qaraabada ee natiijooyinka cabbiradu waa in aanay dhaafin ± 15% marka saxnaanta jaangooyooyinka la tijaabiyo.
1. Ku kaydi qalabka wax baadha 2～30℃.Bakhaarku waa mid deggan ilaa 18 bilood.
2. Ku kaydi cajaladda tijaabada degdegga ah ee Aehealth Ferritin at 2～30℃, cimriga shelf waa ilaa 18 bilood.
3. Cajaladda tijaabada ah waa in lagu isticmaalo 1 saac gudahood ka dib marka xidhmada la furo.
ST2 waa xubin ka mid ah Toll-like reseptor/interleukin-1 (interleukin-1, IL-1) receptor superfamily.IL-33 waa ligand functional gaar ah oo ay sii daayaan by cardiomyocytes iyo fibroblasts.Laba shay oo muujinta hidda-wadaha: transmembrane ST2 (ST2L) iyo sST2.ST2L waxay ka kooban tahay saddex qaybood oo immunoglobulin-ka-baxsan ah, halka sST2 ay ka maqan tahay domains transmembrane iyo intracellular reseptor.Waxay ku xidhaan ligand-ga caadiga ah ee IL-33 waxayna ciyaaraan door bayooloji ah.Jidka calaamadaha ST2L iyo IL-33 waxay leeyihiin saameyno ka hortag ah oo wadnaha ah sida hypertrophy ka hortagga kardiomyocyte, fibrosis myocardial iyo anti-atherosclerosis.Marka culeyska wadnuhu kordho, dheecaanka sST2 ayaa kordha, sST2 oo kordhayna waxay ka hortagtaa IL-33 inay ku darto ST2L, taas oo ka hortagaysa saameynta wadnaha ee IL-33/ST2L ee calaamadaynta.Waxaa la qiyaasayaa in sST2 ay noqon karto dhexdhexaadiyaha cudurka wadnaha ee hypertrophy kardiomyocyte iyo fibrosis myocardial.Go'aaminta tirada ee heerarka sST2 waxay siin kartaa takhaatiirta qalab sax ah si ay uga caawiyaan qiimeynta wadne xanuunka.